申请人:SHIONOGI & CO., LTD.
公开号:EP1085021A1
公开(公告)日:2001-03-21
Compounds having sPLA2 inhibitory effect represented by general formula (I), prodrugs thereof, pharmaceutically acceptable salts thereof or solvates of the same, and sPLA2 inhibitors containing the same as the active ingredient, wherein R1 represents -(L1)-R6 (wherein L1 represents a divalent linking group having 1 to 18 atoms, etc.; and R6 represents a carbon ring having one or more non-interfering substituents, etc.); R2 represents C1-3 alkyl, etc.; R3 represents -(L2)-(acidic group); R4 and R5 represent each hydrogen, a non-interfering substituent, a carbon ring, etc.; Xs independently represent each oxygen or sulfur; and RA represents -C(=X)-C(=X)-NH2, etc.
由通式(I)表示的具有 sPLA2 抑制作用的化合物、其原药、其药学上可接受的盐或其溶 液,以及含有相同物质作为活性成分的 sPLA2 抑制剂,其中 R1 代表-(L1)-R6(其中 L1 代表具有 1 至 18 个原子的二价连接基团等);R6 代表具有一个或多个非干扰取代基的碳环等;R2 代表 C1-3 烷基等;R3 代表-(L2)-(酸性基团)等。R2代表C1-3烷基等;R3代表-(L2)-(酸性基团);R4和R5各自代表氢、非干扰取代基、碳环等;Xs各自独立地代表氧或硫;RA代表-C(=X)-C(=X)-NH2等。